Cyabra Announces Pricing of $6.0 Million Private Placement Priced At a Premium to the Market Price with New and Existing Institutional Investors, Management, and Board Members
Rhea-AI Summary
Cyabra (Nasdaq: CYAB) priced a $6.0 million private placement of 13,818,770 common shares (or equivalents) plus Series A and B warrants at $0.435 per share and accompanying warrants. Series A warrants are exercisable at $0.50 for five years; Series B at $0.45 for twelve months, both following stockholder approval.
Cyabra plans to convert all outstanding Series A and B preferred into 35,648,276 common shares and exchange $10,660,000 of Series C preferred into placement securities, subject to stockholder approval. Net proceeds are intended for working capital and general corporate purposes.
Positive
- Raises approximately $6.0 million in gross proceeds for working capital needs
- Converts 35,648,276 preferred shares into common, simplifying capital structure
- Exchanges $10,660,000 of Series C preferred into new securities
- Participation from new institutional investors plus management and board members
- Preferred share conversion and exchange expected to remove a structural capital overhang
Negative
- Issuance of 13,818,770 new shares plus warrants creates potential dilution
- Conversion of 35,648,276 preferred shares significantly increases common share count
- Additional dilution potential from 27,637,540 Series A and B warrant shares
- Private placement priced at $0.435 may pressure valuation perceptions despite claimed premium
- Closing and preferred conversions remain subject to stockholder approval and customary conditions
Market reaction after $6.0 million private placement: CYAB -21.57% in the Jul 9 session
In the Jul 9 session, CYAB declined 21.57%, reflecting a significant negative market reaction. Argus tracked a trough of -34.0% from its starting point during tracking. Our momentum scanner triggered 28 alerts that day, indicating elevated trading interest and price volatility. Trading volume was exceptionally heavy at 6.9x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 08 | Customer contract win | Positive | +7.5% | Signed agreement worth more than $500,000 with research institute client. |
| Jun 03 | Management appointment | Neutral | -4.5% | Appointed new Chief Marketing Officer to support growth initiatives. |
| May 15 | 1Q26 earnings report | Positive | +1.6% | Reported Q1 2026 revenue growth and higher ARR with strong gross margins. |
| May 05 | Shareholder update | Neutral | -32.9% | Shared post‑listing execution priorities and 2025 revenue overview. |
| Apr 29 | Board appointments | Neutral | -0.7% | Named new board members with government and corporate experience. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has produced mostly modest price reactions, with one shareholder update coinciding with a sharper selloff.
Key Terms
series a warrants financial
series b warrants financial
convertible preferred stock financial
section 4(a)(2) regulatory
regulation d regulatory
registration statement regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
- In conjunction with the Private Placement, all outstanding preferred shares will convert into common stock or common stock equivalents in lieu thereof, subject to stockholder approval
- An existing shareholder, as well as management and board members, are investing new equity as part of the Private Placement
New York, NY, July 09, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) ("Cyabra" or the "Company"), a company whose artificial intelligence ("AI")-powered platform helps governments and enterprises detect coordinated manipulation and protect digital trust, today announced that it has entered into securities purchase agreements with new and existing institutional investors, management, and board members, for the purchase and sale of 13,818,770 shares of common stock (or common stock equivalents in lieu thereof), Series A Warrants to purchase up to 13,818,770 shares of common stock (the “Series A Warrants”) and Series B Warrants to purchase up to 13,818,770 shares of common stock (the “Series B Warrants,” and together with the Series A Warrants, the “Warrants”) at a combined purchase price of
The Series A Warrants will have an exercise price of
In connection with the offering, the Company and its existing holders of the Company’s Series A Convertible Preferred Stock and Series B Convertible Preferred Stock have agreed to amend the conversion price of the preferred shares to
The closing of the Private Placement is expected to occur on or about July 10, 2026, subject to the satisfaction of customary closing conditions. The Company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.
“This private placement and the conversion of our outstanding preferred shares remove a structural overhang and marks an important adjustment of Cyabra's capital structure. We believe that the participation of new institutional investors, together with continued support from existing investors, management, and our board, reflects strong alignment around the Company's next stage of execution,” said Dan Brahmy, Co-Founder and Chief Executive Officer, Cyabra.
A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.
The offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investor, the Company has agreed to file a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) covering the resale of the ordinary shares and ordinary shares underlying warrants sold in the offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Cyabra
Cyabra is an AI-powered narrative intelligence company that helps national security and defense organizations, government agencies, brands, communications agencies, and global enterprises restore trust and authenticity online by analyzing manipulated content, coordinated behaviors, and inauthentic actors. The platform helps teams understand who is operating, how activity is amplified, and where coordinated activity is shaping perception, translating evidence into clear mitigation steps. By reducing ambiguity and misdirected response, Cyabra enables proportionate, evidence-led action when clarity matters most.
For more information, visit www.cyabra.com.
Contact:
Investors: ir@cyabra.com
Media: pr@cyabra.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and statements regarding Cyabra's intent, belief, or expectations, including, but not limited to, statements regarding Cyabra's future results of operations and financial position, planned products and services, business strategy and plans, market size and growth opportunities, competitive position and market trends. Some of these forward-looking statements can be identified by the use of forward-looking words, including "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," "plan," "targets," "projects," "could," "would," "continue," "forecast" or the negatives of these terms or variations of them or similar expressions. For example, the Company is using forward-looking statements in this press release when it discusses the expected proceeds, the intended use of proceeds and the belief that the participation of new institutional investors, together with continued support from existing investors, management, and our board, reflects strong alignment around the Company's next stage of execution. These statements relate to future events and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in Cyabra's filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Cyabra undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.